Search results
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 6 days agoPTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely...
PTC Therapeutics (PTCT) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 12 months agoPTC Therapeutics (PTCT) might move higher on growing optimism about its earnings prospects, which is...
PTC Therapeutics, Inc.'s (NASDAQ:PTCT) Intrinsic Value Is Potentially 75% Above Its Share Price
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights The projected fair value for PTC Therapeutics is US$83.21 based on 2 Stage Free Cash...
PTC Therapeutics, Inc. (NASDAQ:PTCT) Just Released Its Yearly Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 2 months agoShareholders of PTC Therapeutics, Inc. (NASDAQ:PTCT) will be pleased this week, given that the stock...
Is PTC Therapeutics (PTCT) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
GuruFocus.com via Yahoo Finance· 8 months agoValue-focused investors are always on the hunt for stocks that are priced below their intrinsic...
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoPTC Therapeutics (PTCT) delivered earnings and revenue surprises of -14.84% and 2.41%, respectively,...
PTC Therapeutics (NASDAQ:PTCT) shareholders are up 17% this past week, but still in the red over the...
Simply Wall St. via Yahoo Finance· 5 months agoPTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders should be happy to see the share price up 28% in...
PTC Therapeutics Stock Tumbles: Company Stops Preclinical Gene Therapy Programs After Failed...
Benzinga via Yahoo Finance· 11 months agoPTC Therapeutics Inc (NASDAQ: PTCT) reported topline results from the MOVE-FA trial of vatiquinone...
PTC Therapeutics, Inc. (NASDAQ:PTCT) Might Not Be As Mispriced As It Looks After Plunging 25%
Simply Wall St. via Yahoo Finance· 11 months agoPTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders won't be pleased to see that the share price has...
PTC Therapeutics' (PTCT) Rare Disease Drug Fails in Study
Zacks via Yahoo Finance· 11 months agoPTC Therapeutics' (PTCT) vatiquinone did not achieve its primary endpoint in a late-stage study in...